社论：噬菌体疗法：过去、现在与未来 - Suppr

Suppr

超能文献

Editorial: Phage Therapy: Past, Present and Future.

作者信息

Abedon Stephen T, García Pilar, Mullany Peter, Aminov Rustam

机构信息

Department of Microbiology, The Ohio State UniversityMansfield, OH, United States.

Spanish National Research CouncilVillaviciosa, Spain.

出版信息

Front Microbiol. 2017 Jun 15;8:981. doi: 10.3389/fmicb.2017.00981. eCollection 2017.

DOI:10.3389/fmicb.2017.00981

PMID:28663740

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5471325/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72e4/5471325/f5a745e2dcee/fmicb-08-00981-g0001.jpg

相似文献

Editorial: Phage Therapy: Past, Present and Future.

Front Microbiol. 2017 Jun 15;8:981. doi: 10.3389/fmicb.2017.00981. eCollection 2017.

The use of bacteriophages to biocontrol oral biofilms.

J Biotechnol. 2017 May 20;250:29-44. doi: 10.1016/j.jbiotec.2017.01.002. Epub 2017 Jan 17.

Phage and their lysins as biocontrol agents for food safety applications.

Annu Rev Food Sci Technol. 2010;1:449-68. doi: 10.1146/annurev.food.102308.124046.

Mining and multifaceted applications of phage lysin for combatting Vibrio parahaemolyticus.

Food Res Int. 2024 Sep;192:114819. doi: 10.1016/j.foodres.2024.114819. Epub 2024 Jul 30.

Characterization and Genome Analysis of Vibrio campbellii Lytic Bacteriophage OPA17.

Microbiol Spectr. 2023 Jan 31;11(2):e0162322. doi: 10.1128/spectrum.01623-22.

Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.

J Virol. 2021 Jun 24;95(14):e0032121. doi: 10.1128/JVI.00321-21.

Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria.

Pharmaceuticals (Basel). 2015 Sep 9;8(3):559-89. doi: 10.3390/ph8030559.

Phage-derived lysins as potential agents for eradicating biofilms and persisters.

Drug Discov Today. 2018 Apr;23(4):848-856. doi: 10.1016/j.drudis.2018.01.026. Epub 2018 Jan 8.

A Novel Podophage Encodes a Unique Lysin with Unusual Modular Design.

mSphere. 2017 Mar 22;2(2). doi: 10.1128/mSphere.00040-17. eCollection 2017 Mar-Apr.

Bacteriophage-based biocontrol technology to enhance the efficiency of wastewater treatment and reduce targeted bacterial biofilms.

Sci Total Environ. 2023 Mar 1;862:160723. doi: 10.1016/j.scitotenv.2022.160723. Epub 2022 Dec 8.

引用本文的文献

Interaction between gut virome and microbiota on inflammatory bowel disease.

World J Methodol. 2025 Sep 20;15(3):100332. doi: 10.5662/wjm.v15.i3.100332.

Microbial Food Safety and Antimicrobial Resistance in Foods: A Dual Threat to Public Health.

Microorganisms. 2025 Jul 6;13(7):1592. doi: 10.3390/microorganisms13071592.

Exploration of Providers' Perceptions and Attitudes Toward Phage Therapy and Intentions for Future Adoption as an Alternative to Traditional Antibiotics in the US-A Cross-Sectional Study.

Int J Environ Res Public Health. 2025 Jul 18;22(7):1139. doi: 10.3390/ijerph22071139.

Graphene-Bacteriophage Hybrid Nanomaterials for Specific and Rapid Electrochemical Detection of Pathogenic Bacteria.

Biosensors (Basel). 2025 Jul 19;15(7):467. doi: 10.3390/bios15070467.

Characterization and antimicrobial activity of a novel lytic phage vB_SmaS_QH16 against : , , and biofilm studies.

Front Cell Infect Microbiol. 2025 Jul 10;15:1610857. doi: 10.3389/fcimb.2025.1610857. eCollection 2025.

Optimizing bacteriophage screening and isolation methods for microbial samples derived from different body sites of cattle.

bioRxiv. 2025 Jul 5:2025.07.04.663187. doi: 10.1101/2025.07.04.663187.

Phage/nanoparticle cocktails for a biocompatible and environmentally friendly antibacterial therapy.

Appl Microbiol Biotechnol. 2025 May 29;109(1):129. doi: 10.1007/s00253-025-13526-x.

Comparative study on the virulence of mycobacteriophages.

J Virol. 2025 Jun 17;99(6):e0192024. doi: 10.1128/jvi.01920-24. Epub 2025 May 21.

Isolation and characterization of fMGyn-Pae01, a phiKZ-like jumbo phage infecting Pseudomonas aeruginosa.

Virol J. 2025 Mar 4;22(1):55. doi: 10.1186/s12985-025-02679-w.

Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches.

J Clin Invest. 2025 Mar 3;135(5):e187996. doi: 10.1172/JCI187996.

本文引用的文献

History of antimicrobial drug discovery: Major classes and health impact.

Biochem Pharmacol. 2017 Jun 1;133:4-19. doi: 10.1016/j.bcp.2016.10.001. Epub 2016 Oct 5.

More Is Better: Selecting for Broad Host Range Bacteriophages.

Front Microbiol. 2016 Sep 8;7:1352. doi: 10.3389/fmicb.2016.01352. eCollection 2016.

Biocontrol and Rapid Detection of Food-Borne Pathogens Using Bacteriophages and Endolysins.

Front Microbiol. 2016 Apr 8;7:474. doi: 10.3389/fmicb.2016.00474. eCollection 2016.

Silk route to the acceptance and re-implementation of bacteriophage therapy.

Biotechnol J. 2016 May;11(5):595-600. doi: 10.1002/biot.201600023. Epub 2016 Mar 23.

Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model.

Indian J Med Res. 2016 Jan;143(1):87-94. doi: 10.4103/0971-5916.178615.

Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh.

EBioMedicine. 2016 Jan 5;4:124-37. doi: 10.1016/j.ebiom.2015.12.023. eCollection 2016 Feb.

Bacteriophage-encoded depolymerases: their diversity and biotechnological applications.

Appl Microbiol Biotechnol. 2016 Mar;100(5):2141-51. doi: 10.1007/s00253-015-7247-0. Epub 2016 Jan 15.

Safety and efficacy of phage therapy via the intravenous route.

FEMS Microbiol Lett. 2016 Feb;363(3). doi: 10.1093/femsle/fnv242. Epub 2015 Dec 20.

Phage therapy of pulmonary infections.

Bacteriophage. 2015 Apr 18;5(1):e1020260. doi: 10.1080/21597081.2015.1020260. eCollection 2015 Jan-Mar.

Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria.

Pharmaceuticals (Basel). 2015 Sep 9;8(3):559-89. doi: 10.3390/ph8030559.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验